Recent European air-defense procurement, localization and operational initiatives, including a reported Iron Dome ground-system manufacturing program in Germany, underscore growing requirements for launcher, mobility, power-generation, command-and-control and related mission-critical hardware categories served by T3 Defense subsidiaries. NEW YORK and NETANYA, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), a defense company that acquires and operates mission-critical defense businesses involved in national security programs, today highlighted growing European demand for ground-segment subsystems used in layered air- and missile-defense architectures. Recent defense developments in Europe underscore increased investment in integrated air- and missile-defense capabilities,...

Initial Deployment at U.S. Naval Station in Europe Opens Potential Opportunity Across 68 Navy Liberty Locations Worldwide First MWR Sale Expands Omni One’s U.S. Military Applications Beyond Training into Recreation AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) — Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of AI-driven, full-body simulation systems, today announced the sale of its first Omni One Enterprise systems to the U.S. Navy’s Morale, Welfare and Recreation (MWR) Liberty Program. The Omni One units will be deployed in support of a U.S. Naval Station in Europe, marking Virtuix’s first sale to the Navy’s Liberty Program and expanding the Company’s relationship with the U.S. Navy. The Navy’s MWR organization supports the quality of life, well-being, and readiness of Sailors and the broader Navy community. Its Liberty...

Third Acquisition in Less Than 12 Months, Continuing Accelerated Growth Strategy CENTENNIAL, Colo, Sept. 08, 2026 (GLOBE NEWSWIRE) — Family Office of America (OTC: [FOFA]) (“FOFA” or the “Company”) today announced that its subsidiary, Family Office of Maryland, LLC, has entered into an agreement to acquire certain assets of J F Kearney & Associates, P.A., a Maryland-based accounting and tax services practice led by James F. Kearney. The transaction represents the Company’s third acquisition in less than 12 months and marks another significant step in FOFA’s strategy of building a diversified professional and financial services platform through strategic acquisitions and organic growth. J F Kearney & Associates has established a strong reputation for providing accounting and tax-related...

Sanoma Corporation, Stock Exchange Release, 8 September 2026 at 4:15 p.m. EET Sanoma’s financial reporting in 2027 In 2027, Sanoma Corporation will publish financial information as follows: Full-Year Result 2026                                               Thursday, 18 FebruaryInterim Report 1 January–31 March 2027                Wednesday, 28 AprilHalf-Year Report 1 January–30 June 2027               Wednesday, 28 JulyInterim Report 1 January–30 September 2027         Friday, 29 October Sanoma practices a silent period of 30 days prior to publishing financial information. Sanoma’s Financial Statements and Directors’ Report for 2026 will be published during week 10, which starts on 8 March 2027. Sanoma Corporation’s Annual General Meeting (AGM) 2027 is planned to be held on Wednesday, 28 April 2027 in Helsinki. The Board of Directors...

DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for critical materials production, today hosts its inaugural Capital Markets Day in London. Management will outline the Company’s strategy across nuclear medicine, electronics, helium and LNG, and nuclear fuels, and will provide an overview of the building blocks supporting the Company’s long-term growth potential. Over the past 12 months, the Company has moved from development into early commercialization across several of its businesses. At today’s event, management intends to provide a summary of what has been achieved to date, target milestones for the next 12 months, and how the complementary businesses...

BOSTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) — Vystar Corporation (OTCQB: VYST) today announced the completion of a sale of substantially all remaining inventory associated with its Vytex business as the Company continues its strategic repositioning following its acquisition of the R3ALM Financial Ecosystem. Vystar CEO Jamie Rotman stated, “I have completed a sale of substantially all remaining Vytex inventory, consisting of 1,395 individual pieces, including toppers, beds, pillows and covers. All of the inventory has now left our warehouse.” The transaction represents another step in Vystar’s efforts to streamline its legacy operations and concentrate resources on the development of the R3ALM ecosystem. Vystar’s Strategic Focus on R3ALM Vystar is increasingly focused on R3ALM and its potential to participate in the rapidly developing...

Company invited to present alongside global pharmaceutical, biotechnology and industry leaders at five high-profile U.S. and China conferences in September CEO Abizer Gaslightwala to deliver keynote and featured presentations on next-generation ADC payload innovation and partnerships/collaborations TAMPA, Fla. and LONDON, Sept. 08, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced that the Company has been selected to participate in five prominent oncology, ADC and healthcare industry and investor conferences in the United States and China during September 2026. These speaking engagements position Akari’s proprietary PH1 ADC payload technology in front of leading global pharmaceutical...